Booz Allen Hamilton Holding Corporation (BAH) Income Statement

Quarterly revenue has compressed from a $3.1B peak in 2025Q2 to roughly $2.8B in each of the last three periods, an approximately 10% reduction in run-rate that implies roughly $1.2B of annualized volume lost. The moderation from -10.2% to -3.9% may indicate the contraction is bottoming, but six straight negative prints suggest this is more than a one-quarter timing effect. Because BAH's revenue is concentrated in US federal programs, the durability question hinges on whether this reflects expiring scope, competitive losses, or delayed appropriations — a distinction the topline alone cannot resolve.

COGS ranges from $1.3B to $2.5B on essentially flat revenue, which implies the reported gross margin series is not a usable measure of pricing power for this business; operating margin is the more reliable gauge. Excluding the 2025Q2 outlier, operating margin has held a remarkably tight 8.7%–10.0% band, suggesting BAH has defended unit economics even as volume fell. That stability may indicate disciplined bid pricing, but it could equally reflect a shift toward cost-plus contracts where margin is contractual rather than earned — investors should monitor the mix.

The consequence is reverse operating leverage: SG&A intensity rose from about 7.3% of revenue in 2025Q2 to roughly 11.7% in 2027Q2, a shift of more than 400 basis points that absorbed what would otherwise have been margin expansion. Fixed overhead in a labor-intensive consulting model is difficult to shed quickly without triggering clearance-loss or morale costs, so further revenue decline would likely press margins lower. R&D is reported as zero across all periods, which should be treated as data unavailable rather than as evidence of no technical investment.

The 17.4% operating margin coincided with an unusually low $225.4M SG&A line versus the ~$330M norm, so the margin spike looks more like a reporting anomaly than a durable profitability step-change; the lasting inflection is the growth reversal itself. Every quarter since has posted negative revenue growth, erasing roughly $1.2B of annualized volume and shifting the analytical question from capitalizing on expansion to assessing whether the base is stabilizing. For a business whose valuation premium rests on mission-critical incumbency, a sustained break in the growth trend is the single most consequential change in the period reviewed.